Notice of Trading update, Results & presentation
Updated : 07:02
TRISTEL plc
("Tristel" or the "Company")
Notice of Trading update, Results and Investor presentation
Tristel plc (AIM: TSTL), a leading manufacturer of infection prevention and contamination control products, provides notice of a trading update, results and investor presentation.
Shareholder presentation and Trading update
Due to social distancing restrictions and to comply with UK Government directives to avoid non-essential travel, Tristel will not be hosting an Open Day for Shareholders at the Company headquarters in Cambridgeshire this year. However, on 22 July 2020 at 9am a video presentation recorded by Paul Swinney, CEO and Liz Dixon, FD, will be made available on the Company's website:
https://www.tristel.com/uk/investor-centre/investor-presentations.
On the same day the Company will release a Trading update by RNS for the year ended 30 June 2020.
Notice of Results
The Company expects to announce its preliminary results for the year ended 30 June 2020 in mid-October 2020.
Paul Swinney, CEO of Tristel plc, comments: "The safety of our staff and investors is a priority for Tristel and that is why we are providing a virtual presentation to shareholders on 22 July 2020. We look forward to updating shareholders then."
For further information please contact:
Tristel plc | Tel: 01638 721 500 | |
Paul Swinney, Chief Executive Officer | ||
Liz Dixon, Finance Director | ||
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
Lianne Cawthorne | Mob: 07584 391 303 | |
finnCap | Tel: 020 7220 0500 | |
Geoff Nash/ Giles Rolls (Corporate Finance) | ||
Alice Lane (ECM) |
| |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.